ARCHIVES

Two Phase II Trials Display Ramucirumab Potential Efficacy

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

House Encourages NCI To continue Leadership Role As Coordinator Of Cancer Program

October 8, 1999

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

Robert Young To Step Down As Fox Chase Cancer Center President in 2007.

September 29, 2006